:@0.085519:0.075583:0.090751:0.075583:0.090751:0.059604:0.085519:0.059604:0.005232
 :@0.621674:0.075583:0.626906:0.075583:0.626906:0.059604:0.621674:0.059604:0.005232
 :@0.884977:0.940183:0.890322:0.940183:0.890322:0.922163:0.884977:0.922163:0.005345
Oral Presenter Abstract :@0.736982:0.075583:0.918858:0.075583:0.918858:0.059604:0.736982:0.059604:0.011658:0.006331:0.008492:0.004000:0.005293:0.010369:0.006331:0.008929:0.008569:0.008929:0.009573:0.005251:0.008929:0.006382:0.005321:0.010407:0.009403:0.008511:0.005289:0.006275:0.008531:0.008531:0.005340:0.005232
OD-12 :@0.083238:0.078822:0.159838:0.078822:0.159838:0.060055:0.083238:0.060055:0.018529:0.017104:0.007982:0.013255:0.013113:0.006617
using targeted NGS, but all three cases were found with wild-type :@0.085519:0.116012:0.650903:0.116012:0.650903:0.095949:0.085519:0.095949:0.010687:0.009236:0.004761:0.010640:0.010545:0.007236:0.005189:0.009069:0.006760:0.010640:0.009688:0.005189:0.009640:0.010664:0.007260:0.013139:0.013092:0.011901:0.005213:0.007236:0.010664:0.010687:0.005189:0.007212:0.009164:0.004665:0.004761:0.007188:0.005189:0.010640:0.006760:0.009640:0.009759:0.007188:0.009236:0.009164:0.009188:0.009616:0.009236:0.007093:0.013377:0.009759:0.006641:0.009759:0.007188:0.005213:0.010735:0.010545:0.010545:0.010664:0.007260:0.013377:0.004761:0.005094:0.010711:0.007093:0.013377:0.004761:0.004665:0.011082:0.007982:0.005189:0.009212:0.010664:0.009759:0.005951
KRAS:@0.652033:0.116012:0.699710:0.116012:0.699710:0.095949:0.652033:0.095949:0.011806:0.012163:0.011806:0.011901
 using direct sequencing. :@0.699781:0.116012:0.920442:0.116012:0.920442:0.095949:0.699781:0.095949:0.007269:0.010545:0.009236:0.004761:0.010640:0.010545:0.007236:0.010664:0.004761:0.006665:0.009759:0.009236:0.005094:0.007236:0.009236:0.009759:0.010664:0.010687:0.009664:0.010711:0.009236:0.004761:0.010497:0.010640:0.005213:0.005951
Thus, those with variant frequencies of  34.4% in targeted NGS were possibly detected or missed :@0.085519:0.139428:0.920298:0.139428:0.920298:0.119365:0.085519:0.119365:0.010640:0.010711:0.010687:0.009188:0.005213:0.006427:0.005189:0.010640:0.010545:0.009236:0.009759:0.006189:0.013377:0.004761:0.005094:0.010711:0.006236:0.009164:0.009069:0.006760:0.004642:0.009164:0.010759:0.005189:0.006331:0.005213:0.006760:0.009759:0.010664:0.010687:0.009664:0.010711:0.009236:0.004761:0.009640:0.009236:0.006379:0.010545:0.005213:0.005951:0.018440:0.010664:0.010568:0.005213:0.010735:0.016686:0.006379:0.004761:0.010497:0.006379:0.005189:0.009069:0.006760:0.010640:0.009688:0.005189:0.009640:0.010664:0.006427:0.013139:0.013092:0.011901:0.006308:0.013258:0.009759:0.006641:0.009759:0.006331:0.010664:0.010664:0.009188:0.009188:0.004761:0.010664:0.004761:0.009212:0.006284:0.010664:0.009759:0.005094:0.009759:0.009236:0.005094:0.009759:0.010664:0.006355:0.010664:0.006760:0.006355:0.015995:0.004523:0.009236:0.009236:0.009759:0.010664:0.005951
≤:@0.416239:0.139630:0.434067:0.139630:0.434067:0.122782:0.416239:0.122782:0.017828
through  direct  sequencing.  Using  two  molecular  techniques  NGS  and  direct  sequencing,  our :@0.085519:0.162810:0.920090:0.162810:0.920090:0.142747:0.085519:0.142747:0.005189:0.010640:0.006760:0.010664:0.010687:0.010640:0.010711:0.005951:0.005284:0.010664:0.004761:0.006665:0.009759:0.009236:0.005094:0.005951:0.005141:0.009188:0.009616:0.010664:0.010687:0.009759:0.010711:0.009236:0.004665:0.010711:0.010640:0.005213:0.005951:0.005237:0.013139:0.009188:0.004761:0.010545:0.010640:0.005951:0.005332:0.005189:0.013187:0.010664:0.005951:0.005308:0.015829:0.010664:0.004761:0.009664:0.009236:0.010687:0.004761:0.009164:0.006641:0.005951:0.005284:0.005189:0.009640:0.009236:0.010711:0.010711:0.004761:0.010664:0.010687:0.009640:0.009188:0.005951:0.005213:0.013139:0.012949:0.011901:0.005951:0.005356:0.009164:0.010497:0.010664:0.005951:0.005165:0.010664:0.004761:0.006665:0.009759:0.009236:0.005094:0.005951:0.005284:0.009236:0.009545:0.010664:0.010687:0.009759:0.010711:0.009236:0.004665:0.010711:0.010640:0.005213:0.005951:0.005237:0.010545:0.010687:0.006831:0.005951
investigation identified several variants of the :@0.085519:0.186193:0.465482:0.186193:0.465482:0.166130:0.085519:0.166130:0.004761:0.010640:0.009164:0.009640:0.009236:0.005189:0.004642:0.010640:0.009164:0.005189:0.004665:0.010664:0.010711:0.005951:0.004761:0.010664:0.009831:0.010711:0.005118:0.004761:0.005213:0.004761:0.009640:0.010664:0.005951:0.009307:0.009759:0.009045:0.009759:0.006641:0.009164:0.004665:0.005951:0.009164:0.009236:0.006760:0.004642:0.009164:0.010711:0.005070:0.009236:0.005951:0.010664:0.005308:0.005951:0.005189:0.010711:0.009640:0.005951
KRAS:@0.465697:0.186193:0.513303:0.186193:0.513303:0.166130:0.465697:0.166130:0.011806:0.011997:0.011901:0.011901
 gene in patients with CRC.:@0.513350:0.186193:0.741345:0.186193:0.741345:0.166130:0.513350:0.166130:0.005986:0.010640:0.009759:0.010711:0.009664:0.005951:0.004761:0.010711:0.005808:0.010664:0.009164:0.005118:0.004761:0.009640:0.010711:0.005189:0.009307:0.005951:0.013377:0.004761:0.005189:0.010640:0.005951:0.013163:0.012163:0.013044:0.005213
 :@0.741258:0.185833:0.746603:0.185833:0.746603:0.167812:0.741258:0.167812:0.005345
 :@0.085519:0.229631:0.092136:0.229631:0.092136:0.210865:0.085519:0.210865:0.006617